David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Becton Dickinson
BDX
$52.3B
| $107M | 0.12% |
420,613
+108,042
| +35% | +$25.5M |
|
177
State Street SPDR S&P Biotech ETF
XBI
$11.6B
| $107M | 0.12% |
1,286,200
+771,200
| +150% | +$62.4M |
|
178
PUT
Devon Energy
DVN
$54B
| $106M | 0.12% |
1,728,400
+541,000
| +46% | +$36.9M |
|
179
Citigroup
C
$221B
| $106M | 0.12% |
2,333,198
+255,256
| +12% | +$11.6M |
|
180
CBRE Group
CBRE
$44B
| $104M | 0.12% |
1,355,694
-184,197
| -12% | -$13.6M |
|
181
Skyworks Solutions
SWKS
$10.1B
| $104M | 0.12% |
1,144,105
+143,395
| +14% | +$12.9M |
|
182
Cadence Design Systems
CDNS
$87.9B
| $104M | 0.12% |
647,801
+149,035
| +30% | +$23.8M |
|
183
CALL
General Motors
GM
$77.2B
| $104M | 0.11% |
3,077,700
-314,200
| -9% | -$11.6M |
|
184
Chevron
CVX
$403B
| $103M | 0.11% |
573,789
-501,816
| -47% | -$87.6M |
|
185
Elanco Animal Health
ELAN
$12B
| $103M | 0.11% |
8,412,221
+2,790,134
| +50% | +$34.8M |
|
186
Moderna
MRNA
$57.9B
| $102M | 0.11% |
567,008
+294,842
| +108% | +$48.2M |
|
|
LBRDK
187
DELISTED
Liberty Broadband Class C
LBRDK
| $100M | 0.11% |
1,312,852
+78,892
| +6% | +$6.42M |
|
188
VeriSign
VRSN
$25.5B
| $100M | 0.11% |
487,273
-238,596
| -33% | -$45.7M |
|
189
Antero Resources
AR
$11.7B
| $99.9M | 0.11% |
3,224,795
-515,131
| -14% | -$17.8M |
|
190
PUT
Mastercard
MA
$509B
| $99.4M | 0.11% |
285,800
+51,600
| +22% | +$17M |
|
191
CALL
Verizon
VZ
$205B
| $99M | 0.11% |
2,513,300
+1,968,400
| +361% | +$74.2M |
|
192
PUT
Costco
COST
$420B
| $99M | 0.11% |
216,900
+84,700
| +64% | +$41.4M |
|
193
ATI
ATI
$28.2B
| $98.7M | 0.11% |
3,305,890
-91,207
| -3% | -$2.67M |
|
194
Northrop Grumman
NOC
$78.3B
| $98.3M | 0.11% |
180,210
-48,331
| -21% | -$25.2M |
|
195
PUT
Valero Energy
VLO
$100B
| $97.9M | 0.11% |
771,900
+8,800
| +1% | +$1.1M |
|
196
argenx
ARGX
$65B
| $97.4M | 0.11% |
257,027
-71,196
| -22% | -$26.6M |
|
197
PUT
Target
TGT
$75.1B
| $97.3M | 0.11% |
652,700
+71,900
| +12% | +$11.3M |
|
198
CALL
PayPal
PYPL
$52.7B
| $97M | 0.11% |
1,362,500
+252,100
| +23% | +$20.2M |
|
199
PUT
ConocoPhillips
COP
$162B
| $96.9M | 0.11% |
821,200
+284,700
| +53% | +$34.6M |
|
200
CALL
Snowflake
SNOW
$115B
| $96.6M | 0.11% |
673,100
+258,200
| +62% | +$39.4M |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.